Delivery Order SPE2DX22D0010-SPE2D826FCD41
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 16, 2025, for OxyContin Tablets 20mg with a ceiling value of $5,072.23. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor for pharmaceutical supply to support military and federal healthcare operations. The ultimate completion date is November 17, 2025, and the place of performance is AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $3,304.45. This firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 2, 2025, for the supply of OxyContin 20mg tablets under a firm fixed-price contract valued at $5,072.23. This non-set-aside award is scheduled for completion by November 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $5,072.23 to AmerisourceBergen Drug Corp on November 9, 2025, for the supply of OxyContin tablets (20mg). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 8, 2025, for the supply of OxyContin tablets (20 mg) with a ceiling value of $3,184.28. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude on June 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin 20mg tablets under a firm fixed-price contract valued at $5,072.23, with an ultimate completion date of December 29, 2025. This non-set-aside award was issued competitively and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 27, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This firm fixed-price, non-set-aside contract has an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements for...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCD41Delivery Order
The Defense Department's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on January 4, 2026, for the supply of OxyContin tablets (20mg) with a ceiling value of $5,072.23 and an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order was issued under a no set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the products will also be performed. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive federal contract portfolio demonstrating capability to meet diverse federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/3/26 |